February 21, 2018 / 9:55 AM / in 4 months

BRIEF-Fountain Biopharma anti-CεmX antibody receives Europe Patent

Feb 21 (Reuters) - Fountain Biopharma Inc :

* Says its anti-CεmX antibody FB825 received Europe patent, for Anti-CεmX antibodies capable of binding to human mIgE on B lymphocytes

* Patent number is EP2401300B1

Source text in Chinese: goo.gl/2aXnuz

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below